FGFR4 AS A THERAPEUTIC TARGET IN HUMAN ALVEOLAR VERSUS EMBRYONAL RHABDOMYOSARCOMA
Conferences
Crose, L; Etheridge, K; Chen, C; Bentley, R; Linardic, C
Published in: PEDIATRIC BLOOD & CANCER
June 1, 2010
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
PEDIATRIC BLOOD & CANCER
ISSN
1545-5009
Publication Date
June 1, 2010
Volume
54
Issue
6
Start / End Page
792 / 792
Publisher
WILEY-LISS
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Crose, L., Etheridge, K., Chen, C., Bentley, R., & Linardic, C. (2010). FGFR4 AS A THERAPEUTIC TARGET IN HUMAN ALVEOLAR VERSUS EMBRYONAL RHABDOMYOSARCOMA. In PEDIATRIC BLOOD & CANCER (Vol. 54, pp. 792–792). WILEY-LISS.
Crose, Lisa, Katherine Etheridge, Candy Chen, Rex Bentley, and Corinne Linardic. “FGFR4 AS A THERAPEUTIC TARGET IN HUMAN ALVEOLAR VERSUS EMBRYONAL RHABDOMYOSARCOMA.” In PEDIATRIC BLOOD & CANCER, 54:792–792. WILEY-LISS, 2010.
Crose L, Etheridge K, Chen C, Bentley R, Linardic C. FGFR4 AS A THERAPEUTIC TARGET IN HUMAN ALVEOLAR VERSUS EMBRYONAL RHABDOMYOSARCOMA. In: PEDIATRIC BLOOD & CANCER. WILEY-LISS; 2010. p. 792–792.
Crose, Lisa, et al. “FGFR4 AS A THERAPEUTIC TARGET IN HUMAN ALVEOLAR VERSUS EMBRYONAL RHABDOMYOSARCOMA.” PEDIATRIC BLOOD & CANCER, vol. 54, no. 6, WILEY-LISS, 2010, pp. 792–792.
Crose L, Etheridge K, Chen C, Bentley R, Linardic C. FGFR4 AS A THERAPEUTIC TARGET IN HUMAN ALVEOLAR VERSUS EMBRYONAL RHABDOMYOSARCOMA. PEDIATRIC BLOOD & CANCER. WILEY-LISS; 2010. p. 792–792.
Published In
PEDIATRIC BLOOD & CANCER
ISSN
1545-5009
Publication Date
June 1, 2010
Volume
54
Issue
6
Start / End Page
792 / 792
Publisher
WILEY-LISS
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis